{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T02:13:12Z","timestamp":1792462392454,"version":"4.5.0"},"reference-count":74,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T00:00:00Z","timestamp":1666224000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","award":["C49940\/A17480"],"award-info":[{"award-number":["C49940\/A17480"]}],"id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hotspot mutations in the PEST-domain of <jats:italic>NOTCH1<\/jats:italic> and <jats:italic>NOTCH2<\/jats:italic> are recurrently identified in B cell malignancies. To address how <jats:italic>NOTCH<\/jats:italic>-mutations contribute to a dismal prognosis, we have generated isogenic primary human tumor cells from patients with Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL), differing only in their expression of the intracellular domain (ICD) of NOTCH1 or NOTCH2. Our data demonstrate that both NOTCH-paralogs facilitate immune-escape of malignant B cells by up-regulating PD-L1, partly dependent on autocrine interferon-\u03b3 signaling. In addition, NOTCH-activation causes silencing of the entire <jats:italic>HLA-class II<\/jats:italic> locus via epigenetic regulation of the transcriptional co-activator CIITA. Notably, while NOTCH1 and NOTCH2 govern similar transcriptional programs, disease-specific differences in their expression levels can favor paralog-specific selection. Importantly, NOTCH-ICD also strongly down-regulates the expression of CD19, possibly limiting the effectiveness of immune-therapies. These NOTCH-mediated immune escape mechanisms are associated with the expansion of exhausted CD8<jats:sup>+<\/jats:sup> T cells in vivo.<\/jats:p>","DOI":"10.1038\/s41467-022-33739-2","type":"journal-article","created":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T12:05:59Z","timestamp":1666267559000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape"],"prefix":"10.1038","volume":"13","author":[{"given":"Maurizio","family":"Mangolini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3365-3775","authenticated-orcid":false,"given":"Alba","family":"Maiques-Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Charalampopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Gerhard-Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1433-9702","authenticated-orcid":false,"given":"Johannes","family":"Bloehdorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2875-6315","authenticated-orcid":false,"given":"Andrew","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgia","family":"Giachetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9211-0746","authenticated-orcid":false,"given":"Junyan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valar Nila","family":"Roamio Franklin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandra Sekkar Reddy","family":"Chilamakuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4584-7849","authenticated-orcid":false,"given":"Ilias","family":"Moutsopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Stilgenbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-9845","authenticated-orcid":false,"given":"Thorsten","family":"Zenz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Mohorianu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clive","family":"D\u2019Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0632-5036","authenticated-orcid":false,"given":"Silvia","family":"Deaglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6225-2033","authenticated-orcid":false,"given":"Daniel J.","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8809-5195","authenticated-orcid":false,"given":"Jose I.","family":"Martin-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7247-311X","authenticated-orcid":false,"given":"Ingo","family":"Ringshausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,20]]},"reference":[{"key":"33739_CR1","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1056\/NEJMoa1801445","volume":"378","author":"R Schmitz","year":"2018","unstructured":"Schmitz, R. et al. Genetics and pathogenesis of diffuse large B-cell lymphoma. N. Engl. J. Med. 378, 1396\u20131407 (2018).","journal-title":"N. Engl. J. Med."},{"key":"33739_CR2","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41591-018-0016-8","volume":"24","author":"B Chapuy","year":"2018","unstructured":"Chapuy, B. et al. Molecular subtypes of diffuse large B cell lymphoma are associated with distinct pathogenic mechanisms and outcomes. Nat. Med. 24, 679\u2013690 (2018).","journal-title":"Nat. Med."},{"key":"33739_CR3","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1182\/blood.2019003535","volume":"135","author":"SE Lacy","year":"2020","unstructured":"Lacy, S. E. et al. Targeted sequencing in DLBCL, molecular subtypes, and outcomes: a Haematological Malignancy Research Network report. Blood 135, 1759\u20131771 (2020).","journal-title":"Blood"},{"key":"33739_CR4","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/ng.1032","volume":"44","author":"V Quesada","year":"2012","unstructured":"Quesada, V. et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat. Genet. 44, 47\u201352 (2012).","journal-title":"Nat. Genet."},{"key":"33739_CR5","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente, X. S. et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature 526, 519\u2013524 (2015).","journal-title":"Nature"},{"key":"33739_CR6","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.cell.2013.01.019","volume":"152","author":"DA Landau","year":"2013","unstructured":"Landau, D. A. et al. Evolution and impact of subclonal mutations in chronic lymphocytic leukemia. Cell 152, 714\u2013726 (2013).","journal-title":"Cell"},{"key":"33739_CR7","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau, D. A. et al. Mutations driving CLL and their evolution in progression and relapse. Nature 526, 525\u2013530 (2015).","journal-title":"Nature"},{"key":"33739_CR8","doi-asserted-by":"publisher","first-page":"6955","DOI":"10.1073\/pnas.102181599","volume":"99","author":"R Bichi","year":"2002","unstructured":"Bichi, R. et al. Human chronic lymphocytic leukemia modeled in mouse by targeted TCL1 expression. Proc. Natl Acad. Sci. USA 99, 6955\u20136960 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33739_CR9","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/S0145-2126(98)00154-4","volume":"23","author":"A Stacchini","year":"1999","unstructured":"Stacchini, A. et al. MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation. Leuk. Res. 23, 127\u2013136 (1999).","journal-title":"Leuk. Res."},{"key":"33739_CR10","doi-asserted-by":"publisher","first-page":"18","DOI":"10.4161\/onci.1.1.18400","volume":"1","author":"A Ros\u00e9n","year":"2012","unstructured":"Ros\u00e9n, A. et al. Lymphoblastoid cell line with B1 cell characteristics established from a chronic lymphocytic leukemia clone by in vitro EBV infection. Oncoimmunology 1, 18\u201327 (2012).","journal-title":"Oncoimmunology"},{"key":"33739_CR11","doi-asserted-by":"publisher","first-page":"4676","DOI":"10.1182\/blood.V88.12.4676.bloodjournal88124676","volume":"88","author":"M Cantwell","year":"1996","unstructured":"Cantwell, M., Sharma, S., Friedmann, T. & Kipps, T. Adenovirus vector infection of chronic lymphocytic leukemia B cells. Blood 88, 4676\u20134683 (1996).","journal-title":"Blood"},{"key":"33739_CR12","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/sj.leu.2404863","volume":"21","author":"M Seiffert","year":"2007","unstructured":"Seiffert, M., Stilgenbauer, S., D\u00f6hner, H. & Lichter, P. Efficient nucleofection of primary human B cells and B-CLL cells induces apoptosis, which depends on the microenvironment and on the structure of transfected nucleic acids. Leukemia 21, 1977\u20131983 (2007).","journal-title":"Leukemia"},{"key":"33739_CR13","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1182\/blood-2017-10-764373","volume":"131","author":"XS Puente","year":"2018","unstructured":"Puente, X. S., Jares, P. & Campo, E. Chronic lymphocytic leukemia and mantle cell lymphoma: crossroads of genetic and microenvironment interactions. Blood 131, 2283\u20132296 (2018).","journal-title":"Blood"},{"key":"33739_CR14","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1182\/blood-2011-09-379966","volume":"119","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 119, 521\u2013529 (2012).","journal-title":"Blood"},{"key":"33739_CR15","doi-asserted-by":"publisher","first-page":"1100","DOI":"10.1038\/leu.2012.357","volume":"27","author":"N Villamor","year":"2013","unstructured":"Villamor, N. et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia 27, 1100\u20131106 (2013).","journal-title":"Leukemia"},{"key":"33739_CR16","doi-asserted-by":"publisher","first-page":"3247","DOI":"10.1182\/blood-2014-01-546150","volume":"123","author":"S Stilgenbauer","year":"2014","unstructured":"Stilgenbauer, S. et al. Gene mutations and treatment outcome in chronic lymphocytic leukemia: results from the CLL8 trial. Blood 123, 3247\u20133254 (2014).","journal-title":"Blood"},{"key":"33739_CR17","doi-asserted-by":"publisher","first-page":"1389","DOI":"10.1084\/jem.20110921","volume":"208","author":"G Fabbri","year":"2011","unstructured":"Fabbri, G. et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J. Exp. Med. 208, 1389\u20131401 (2011).","journal-title":"J. Exp. Med."},{"key":"33739_CR18","doi-asserted-by":"publisher","first-page":"18250","DOI":"10.1073\/pnas.1314608110","volume":"110","author":"S Be\u00e0","year":"2013","unstructured":"Be\u00e0, S. et al. Landscape of somatic mutations and clonal evolution in mantle cell lymphoma. Proc. Natl Acad. Sci. USA 110, 18250\u201318255 (2013).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33739_CR19","doi-asserted-by":"publisher","first-page":"201702564","DOI":"10.1073\/pnas.1702564114","volume":"114","author":"G Fabbri","year":"2017","unstructured":"Fabbri, G. et al. Common nonmutational NOTCH1 activation in chronic lymphocytic leukemia. Proc. Natl Acad. Sci. 114, 201702564 (2017).","journal-title":"Proc. Natl Acad. Sci."},{"key":"33739_CR20","doi-asserted-by":"publisher","first-page":"1882","DOI":"10.1038\/leu.2016.383","volume":"31","author":"F Arruga","year":"2017","unstructured":"Arruga, F. et al. Mutations in NOTCH1 PEST domain orchestrate CCL19-driven homing of chronic lymphocytic leukemia cells by modulating the tumor suppressor gene DUSP22. Leukemia 31, 1882\u20131893 (2017).","journal-title":"Leukemia"},{"key":"33739_CR21","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1038\/leu.2013.319","volume":"28","author":"F Arruga","year":"2014","unstructured":"Arruga, F. et al. Functional impact of NOTCH1 mutations in chronic lymphocytic leukemia. Leukemia 28, 1060\u20131070 (2014).","journal-title":"Leukemia"},{"key":"33739_CR22","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1038\/leu.2017.296","volume":"32","author":"D Benedetti","year":"2018","unstructured":"Benedetti, D. et al. NOTCH1 mutations are associated with high CD49d expression in chronic lymphocytic leukemia: link between the NOTCH1 and the NF-\u03baB pathways. Leukemia 32, 654\u2013662 (2018).","journal-title":"Leukemia"},{"key":"33739_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12494-x","volume":"10","author":"R Caeser","year":"2019","unstructured":"Caeser, R. et al. Genetic modification of primary human B cells to model high-grade lymphoma. Nat. Commun. 10, 4543 (2019).","journal-title":"Nat. Commun."},{"key":"33739_CR24","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nature10113","volume":"475","author":"XS Puente","year":"2011","unstructured":"Puente, X. S. et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 475, 101\u2013105 (2011).","journal-title":"Nature"},{"key":"33739_CR25","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1182\/blood-2008-02-139725","volume":"113","author":"E Rosati","year":"2009","unstructured":"Rosati, E. et al. Constitutively activated Notch signaling is involved in survival and apoptosis resistance of B-CLL cells. Blood 113, 856\u2013865 (2009).","journal-title":"Blood"},{"key":"33739_CR26","doi-asserted-by":"publisher","first-page":"462","DOI":"10.1038\/s41375-019-0571-0","volume":"34","author":"F Arruga","year":"2020","unstructured":"Arruga, F. et al. Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter\u2019s syndrome: therapeutic implications. Leukemia 34, 462\u2013477 (2020).","journal-title":"Leukemia"},{"key":"33739_CR27","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1038\/s41388-019-1053-6","volume":"39","author":"M L\u00f3pez-Guerra","year":"2020","unstructured":"L\u00f3pez-Guerra, M. et al. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells. Oncogene 39, 1185\u20131197 (2020).","journal-title":"Oncogene"},{"key":"33739_CR28","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1182\/blood-2012-05-429282","volume":"121","author":"DG Oscier","year":"2013","unstructured":"Oscier, D. G. et al. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 121, 468\u2013475 (2013).","journal-title":"Blood"},{"key":"33739_CR29","doi-asserted-by":"publisher","first-page":"5173","DOI":"10.1182\/blood-2007-08-108605","volume":"111","author":"PEM Patten","year":"2008","unstructured":"Patten, P. E. M. et al. CD38 expression in chronic lymphocytic leukemia is regulated by the tumor microenvironment. Blood 111, 5173\u20135181 (2008).","journal-title":"Blood"},{"key":"33739_CR30","doi-asserted-by":"publisher","first-page":"15454","DOI":"10.1073\/pnas.0702891104","volume":"104","author":"MA Santos","year":"2007","unstructured":"Santos, M. A. et al. Notch1 engagement by Delta-like-1 promotes differentiation of B lymphocytes to antibody-secreting cells. Proc. Natl Acad. Sci. USA 104, 15454\u201315459 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"33739_CR31","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1182\/blood-2011-10-386144","volume":"119","author":"V Balatti","year":"2012","unstructured":"Balatti, V. et al. NOTCH1 mutations in CLL associated with trisomy 12. Blood 119, 329\u2013331 (2012).","journal-title":"Blood"},{"key":"33739_CR32","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1002\/gcc.21972","volume":"51","author":"C L\u00f3pez","year":"2012","unstructured":"L\u00f3pez, C. et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes Cancer 51, 881\u2013889 (2012).","journal-title":"Genes Chromosomes Cancer"},{"key":"33739_CR33","doi-asserted-by":"publisher","first-page":"2273","DOI":"10.1084\/jem.20131448","volume":"210","author":"G Fabbri","year":"2013","unstructured":"Fabbri, G. et al. Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome. J. Exp. Med. 210, 2273\u20132288 (2013).","journal-title":"J. Exp. Med."},{"key":"33739_CR34","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1172\/JCI93801","volume":"128","author":"S Dietrich","year":"2018","unstructured":"Dietrich, S. et al. Drug-perturbation-based stratification of blood cancer. J. Clin. Investig. 128, 427\u2013445 (2018).","journal-title":"J. Clin. Investig."},{"key":"33739_CR35","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/nature09906","volume":"473","author":"J Ernst","year":"2011","unstructured":"Ernst, J. et al. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature 473, 43\u201349 (2011).","journal-title":"Nature"},{"key":"33739_CR36","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/s41591-018-0028-4","volume":"24","author":"R Beekman","year":"2018","unstructured":"Beekman, R. et al. The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia. Nat. Med. 24, 868\u2013880 (2018).","journal-title":"Nat. Med."},{"key":"33739_CR37","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2012.17","volume":"2","author":"AHN Kamdje","year":"2012","unstructured":"Kamdje, A. H. N. et al. Role of stromal cell-mediated Notch signaling in CLL resistance to chemotherapy. Blood cancer J. 2, e73 (2012).","journal-title":"Blood cancer J."},{"key":"33739_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06069-5","volume":"9","author":"M Mangolini","year":"2018","unstructured":"Mangolini, M. et al. Notch2 controls non-autonomous Wnt-signalling in chronic lymphocytic leukaemia. Nat. Commun. 9, 3839 (2018).","journal-title":"Nat. Commun."},{"key":"33739_CR39","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/j.it.2006.07.007","volume":"27","author":"KL Wright","year":"2006","unstructured":"Wright, K. L. & Ting, J. P.-Y. Epigenetic regulation of MHC-II and CIITA genes. Trends Immunol. 27, 405\u2013412 (2006).","journal-title":"Trends Immunol."},{"key":"33739_CR40","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1182\/blood-2005-04-1510","volume":"107","author":"LM Rimsza","year":"2005","unstructured":"Rimsza, L. M. et al. Loss of major histocompatibility class II expression in non-immune-privileged site diffuse large B-cell lymphoma is highly coordinated and not due to chromosomal deletions. Blood 107, 1101\u20131107 (2005).","journal-title":"Blood"},{"key":"33739_CR41","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1182\/blood-2005-11-4742","volume":"108","author":"RA Roberts","year":"2006","unstructured":"Roberts, R. A. et al. Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survival. Blood 108, 311\u2013318 (2006).","journal-title":"Blood"},{"key":"33739_CR42","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1038\/nature08987","volume":"464","author":"ICG Consortium","year":"2010","unstructured":"Consortium, I. C. G. et al. International network of cancer genome projects. Nature 464, 993\u2013998 (2010).","journal-title":"Nature"},{"key":"33739_CR43","doi-asserted-by":"publisher","first-page":"3994","DOI":"10.1200\/JCO.2008.21.1128","volume":"27","author":"S Stilgenbauer","year":"2009","unstructured":"Stilgenbauer, S. et al. Subcutaneous alemtuzumab in fludarabine-refractory chronic lymphocytic leukemia: clinical results and prognostic marker analyses from the CLL2H study of the German Chronic Lymphocytic Leukemia Study Group. J. Clin. Oncol. 27, 3994\u20134001 (2009).","journal-title":"J. Clin. Oncol."},{"key":"33739_CR44","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3324\/haematol.2012.077537","volume":"98","author":"D Brusa","year":"2013","unstructured":"Brusa, D. et al. The PD-1\/PD-L1 axis contributes to T-cell dysfunction in chronic lymphocytic leukemia. Haematologica 98, 953\u2013963 (2013).","journal-title":"Haematologica"},{"key":"33739_CR45","doi-asserted-by":"publisher","first-page":"1374","DOI":"10.2119\/molmed.2011.00360","volume":"17","author":"C Calissano","year":"2011","unstructured":"Calissano, C. et al. Intraclonal complexity in chronic lymphocytic leukemia: fractions enriched in recently born\/divided and older\/quiescent cells. Mol. Med. 17, 1374\u20131382 (2011).","journal-title":"Mol. Med."},{"key":"33739_CR46","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nature25015","volume":"553","author":"J Zhang","year":"2018","unstructured":"Zhang, J. et al. Cyclin D\u2013CDK4 kinase destabilizes PD-L1 via cullin 3\u2013SPOP to control cancer immune surveillance. Nature 553, 91\u201395 (2018).","journal-title":"Nature"},{"key":"33739_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1084\/jem.177.1.213","volume":"177","author":"M Buschle","year":"1993","unstructured":"Buschle, M. et al. Interferon gamma inhibits apoptotic cell death in B cell chronic lymphocytic leukemia. J. Exp. Med. 177, 213\u2013218 (1993).","journal-title":"J. Exp. Med."},{"key":"33739_CR48","doi-asserted-by":"publisher","first-page":"e360","DOI":"10.3324\/haematol.2016.160374","volume":"102","author":"A Navarro","year":"2017","unstructured":"Navarro, A. et al. Improved classification of leukemic B-cell lymphoproliferative disorders using a transcriptional and genetic classifier. Haematologica 102, e360\u2013e363 (2017).","journal-title":"Haematologica"},{"key":"33739_CR49","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1128\/MCB.18.4.2324","volume":"18","author":"A Bigas","year":"1998","unstructured":"Bigas, A., Martin, D. I. K. & Milner, L. A. Notch1 and Notch2 inhibit myeloid differentiation in response to different cytokines. Mol. Cell Biol. 18, 2324\u20132333 (1998).","journal-title":"Mol. Cell Biol."},{"key":"33739_CR50","doi-asserted-by":"publisher","first-page":"3593","DOI":"10.1242\/dev.063610","volume":"138","author":"ER Andersson","year":"2011","unstructured":"Andersson, E. R., Sandberg, R. & Lendahl, U. Notch signaling: simplicity in design, versatility in function. Development 138, 3593\u20133612 (2011).","journal-title":"Development"},{"key":"33739_CR51","doi-asserted-by":"publisher","first-page":"873","DOI":"10.1038\/nmeth.4391","volume":"14","author":"D Schapiro","year":"2017","unstructured":"Schapiro, D. et al. histoCAT: analysis of cell phenotypes and interactions in multiplex image cytometry data. Nat. Methods 14, 873\u2013876 (2017).","journal-title":"Nat. Methods"},{"key":"33739_CR52","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1182\/blood-2011-11-391474","volume":"119","author":"R Kridel","year":"2012","unstructured":"Kridel, R. et al. Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood 119, 1963\u20131971 (2012).","journal-title":"Blood"},{"key":"33739_CR53","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1038\/leu.2017.90","volume":"31","author":"F Pozzo","year":"2017","unstructured":"Pozzo, F. et al. NOTCH1-mutated chronic lymphocytic leukemia cells are characterized by a MYC-related overexpression of nucleophosmin 1 and ribosome-associated components. Leukemia 31, 2407\u20132415 (2017).","journal-title":"Leukemia"},{"key":"33739_CR54","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1111\/j.1365-2141.2009.07816.x","volume":"146","author":"MD Ianni","year":"2009","unstructured":"Ianni, M. D. et al. A new genetic lesion in B-CLL: a NOTCH1 PEST domain mutation. Br. J. Haematol. 146, 689\u2013691 (2009).","journal-title":"Br. J. Haematol."},{"key":"33739_CR55","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1111\/j.1365-2141.2012.09155.x","volume":"158","author":"D Rossi","year":"2012","unstructured":"Rossi, D. et al. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. Br. J. Haematol. 158, 426\u2013429 (2012).","journal-title":"Br. J. Haematol."},{"key":"33739_CR56","doi-asserted-by":"publisher","first-page":"4101","DOI":"10.1182\/blood-2014-01-552307","volume":"123","author":"JC Riches","year":"2014","unstructured":"Riches, J. C. et al. Trisomy 12 chronic lymphocytic leukemia cells exhibit upregulation of integrin signaling that is modulated by NOTCH1 mutations. Blood 123, 4101\u20134110 (2014).","journal-title":"Blood"},{"key":"33739_CR57","doi-asserted-by":"publisher","first-page":"4251","DOI":"10.1182\/blood-2003-07-2365","volume":"103","author":"LM Rimsza","year":"2004","unstructured":"Rimsza, L. M. et al. Loss of MHC class II gene and protein expression in diffuse large B-cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the Leukemia and Lymphoma Molecular Profiling Project. Blood 103, 4251\u20134258 (2004).","journal-title":"Blood"},{"key":"33739_CR58","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1126\/science.8197455","volume":"264","author":"J Darnell","year":"1994","unstructured":"Darnell, J., Kerr, I. & Stark, G. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264, 1415\u20131421 (1994).","journal-title":"Science"},{"key":"33739_CR59","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1038\/sj.bjc.6601602","volume":"90","author":"Y Morimoto","year":"2004","unstructured":"Morimoto, Y. et al. Inactivation of class II transactivator by DNA methylation and histone deacetylation associated with absence of HLA-DR induction by interferon-\u03b3 in haematopoietic tumour cells. Br. J. Cancer 90, 844\u2013852 (2004).","journal-title":"Br. J. Cancer"},{"key":"33739_CR60","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3109\/10428194.2015.1068308","volume":"57","author":"EM Hartmann","year":"2016","unstructured":"Hartmann, E. M., Rudelius, M., Burger, J. A. & Rosenwald, A. CCL3 chemokine expression by chronic lymphocytic leukemia cells orchestrates the composition of the microenvironment in lymph node infiltrates. Leuk. lymphoma 57, 563\u2013571 (2016).","journal-title":"Leuk. lymphoma"},{"key":"33739_CR61","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1182\/blood-2008-07-170415","volume":"113","author":"JA Burger","year":"2009","unstructured":"Burger, J. A. et al. High-level expression of the T-cell chemokines CCL3 and CCL4 by chronic lymphocytic leukemia B cells in nurselike cell cocultures and after BCR stimulation. Blood 113, 3050\u20133058 (2009).","journal-title":"Blood"},{"key":"33739_CR62","doi-asserted-by":"publisher","first-page":"5463","DOI":"10.1182\/blood-2010-12-324210","volume":"117","author":"D Bagnara","year":"2011","unstructured":"Bagnara, D. et al. A novel adoptive transfer model of chronic lymphocytic leukemia suggests a key role for T lymphocytes in the disease. Blood 117, 5463\u20135472 (2011).","journal-title":"Blood"},{"key":"33739_CR63","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.celrep.2013.07.011","volume":"4","author":"A Os","year":"2013","unstructured":"Os, A. et al. Chronic lymphocytic leukemia cells are activated and proliferate in response to specific T helper cells. Cell Rep. 4, 566\u2013577 (2013).","journal-title":"Cell Rep."},{"key":"33739_CR64","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-019-5971-z","volume":"19","author":"M Gauthier","year":"2019","unstructured":"Gauthier, M. et al. Prognostic role of CD4 T-cell depletion after frontline fludarabine, cyclophosphamide and rituximab in chronic lymphocytic leukaemia. BMC Cancer 19, 809 (2019).","journal-title":"BMC Cancer"},{"key":"33739_CR65","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.leukres.2010.08.010","volume":"35","author":"G D\u2019Arena","year":"2011","unstructured":"D\u2019Arena, G. et al. Regulatory T-cell number is increased in chronic lymphocytic leukemia patients and correlates with progressive disease. Leuk. Res. 35, 363\u2013368 (2011).","journal-title":"Leuk. Res."},{"key":"33739_CR66","doi-asserted-by":"publisher","first-page":"2642","DOI":"10.1182\/bloodadvances.2019000360","volume":"3","author":"Ide Weerdt","year":"2019","unstructured":"Weerdt, Ide et al. Distinct immune composition in lymph node and peripheral blood of CLL patients is reshaped during venetoclax treatment. Blood Adv. 3, 2642\u20132652 (2019).","journal-title":"Blood Adv."},{"key":"33739_CR67","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1182\/blood-2015-01-622936","volume":"126","author":"F McClanahan","year":"2015","unstructured":"McClanahan, F. et al. PD-L1 checkpoint blockade prevents immune dysfunction and leukemia development in a mouse model of chronic lymphocytic leukemia. Blood 126, 203\u2013211 (2015).","journal-title":"Blood"},{"key":"33739_CR68","unstructured":"Hanna, B. S. et al. Combining ibrutinib and checkpoint blockade improves CD8+ T-cell function and control of chronic lymphocytic leukemia in Em-TCL1 mice. Haematologica, haematol.2019.238154 (2020)"},{"key":"33739_CR69","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1182\/blood-2012-02-411678","volume":"120","author":"AG Ramsay","year":"2012","unstructured":"Ramsay, A. G., Clear, A. J., Fatah, R. & Gribben, J. G. Multiple inhibitory ligands induce impaired T-cell immunologic synapse function in chronic lymphocytic leukemia that can be blocked with lenalidomide: establishing a reversible immune evasion mechanism in human cancer. Blood 120, 1412\u20131421 (2012).","journal-title":"Blood"},{"key":"33739_CR70","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1182\/blood.2020006073","volume":"137","author":"N Ioannou","year":"2021","unstructured":"Ioannou, N. et al. Triggering interferon signaling in T cells with avadomide sensitizes CLL to anti-PD-L1\/PD-1 immunotherapy. Blood 137, 216\u2013231 (2021).","journal-title":"Blood"},{"key":"33739_CR71","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1182\/blood-2017-02-765685","volume":"129","author":"W Ding","year":"2017","unstructured":"Ding, W. et al. Pembrolizumab in patients with CLL and Richter transformation or with relapsed CLL. Blood 129, 3419\u20133427 (2017).","journal-title":"Blood"},{"key":"33739_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04619-5","volume":"9","author":"EK Papachristou","year":"2018","unstructured":"Papachristou, E. K. et al. A quantitative mass spectrometry-based approach to monitor the dynamics of endogenous chromatin-associated protein complexes. Nat. Commun. 9, 2311 (2018).","journal-title":"Nat. Commun."},{"key":"33739_CR73","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47\u2013e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"33739_CR74","first-page":"gky1106","volume":"47","author":"Y Perez-Riverol","year":"2018","unstructured":"Perez-Riverol, Y. et al. The PRIDE database and related tools and resources in 2019: improving support for quantification data. Nucleic Acids Res. 47, gky1106 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33739-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33739-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,20]],"date-time":"2022-10-20T23:06:14Z","timestamp":1666307174000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-022-33739-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,20]]},"references-count":74,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["33739"],"URL":"https:\/\/doi.org\/10.1038\/s41467-022-33739-2","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,20]]},"assertion":[{"value":"17 January 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 September 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 October 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6220"}}